|
Biomaterial uses of F/P micro/nanoparticles (F/P M/NPs) | Reported results | Year of publication | References |
|
(1) Heparin neutralizer | (i) Protamine is a competent heparin neutralizer |
1997 |
[37] |
(ii) Postimplantation administration of protamine reduced the thrombotic complication and remarkably reduced the lengthy bed rest period as well as the hospital stay of the patients |
(iii) Post-protamine injection reactions of the patients such as transient back pain, hypotension, and skin rashes were well managed in vitro |
(iv) Severe groin hematoma was observed at a minimal percentage |
|
(2) Cell carriers | (i) F/P MPs enhanced the viabilities of various stem cells such as hMVECs, human dermal fibroblasts, and ADSCs in suspension culture | 2010 |
[39] |
(ii) F/P MPs adhered into the surfaces of the cells, induced cell aggregation, and promoted cell growth |
(iii) Cell aggregates secreted increased amount of heparin-binding growth factors such as FGF |
(iv) F/P MPs induced neovascularization in nude mice model |
(v) Possible angiogenic biomaterial |
(i) When F/P MPs were coated on the culture plate, the quiescent state of hepatic stellate RI-T cells (HSCs) was conserved in comparison to those grown under noncoated and matrigel-coated plates | 2012 |
[43] |
(ii) HSCs exhibited suppressed the expressions of collagen IαI and TGF-β 1 mRNA levels |
(i) F/P NPs reduced the expansion period of human multilineage ASCs and BMSCs despite the absence of animal serum | 2012 |
[42] |
(ii) F/P NPs induced rapid proliferation rates of ASCs and BMSCs |
(iii) ASCs and BMSCs maintained their markers and exhibited their rapid multilineage differentiation |
(iv) F/P NP-coated plates are a useful substratum for the adherence and proliferation of ASCs and BMSCs despite low levels of PRP and FGF-2 |
(i) F/P rapid cell proliferation rate of IR-ASCs under 3D-culture gel system at a low inbred-rat serum content | 2013 |
[40] |
(ii) F/P expedited not only the local cell proliferation but also the vascularization and tissue granulation at the injection sites after transplantation |
|
(3) Cytokine immobilizer or attractant/biomaterial for cell growth and differentiation | (i) Heparin MPs coating immobilized cytokines, namely, SCF, Tpo, and Flt-3 ligand |
2009 |
[44] |
(ii) Controlled gradual release of the cytokines into the media was demonstrated to occur within 3-4 culture days |
(iii) Superior CD 34 (+) hematopoietic progenitor cells proliferation rates were shown at approximately 8.0-fold and over 31.9-fold after 6 and after 12 culture days, respectively |
(i) F/P controlled the gradual release of heparin-binding growth factors like FGF-2 and cytokines such as IL-3 and GM-CSF into the culture media | 2009 |
[41] |
(ii) F/P enhanced the cell growth of hMVECs, human dermal fibroblast cells (hDFCs), and hematopoietic cell line (TF-1) cells when they were used coating agents despite the low level of FBS in the culture media |
|
(4) Hair growth enhancer | (i) Dalteparin (F; identical to fragmin) and protamine microparticles injection (F/P MPs) facilitated increased hair growth | 2011 |
[7] |
(ii) Microscopic findings showed thickened epithelium, proliferation of collagen fibers and fibroblasts, and increased vessels around follicles |
(iii) F/P MPs showed a promising therapeutic use in dermatology particularly on hair reconstruction for alopecia |
|
(5) DNA/protamine injectable dental complex/drug carrier | (i) DNA/protamine complex delayed the growth of certain bacterial species, namely, Staphylococcusaureus, Pseudomonas aeruginosa, Porphyromonas gingivalis, and Prevotella intermedia | 2011 |
[6] |
(ii) An effective drug carrier for gum pocket treatment |
(iii) DNA/protamine complex promoted GTR and GBR |
|
(6) Protein carrier | (i) F/P MPs are competent carrier of the proteins present in the human PRP that stimulate neovascularization and granulation tissue formation | 2011 |
[46] |
(ii) F/P MPs effectively adsorb growth factors GFs |
(iii) F/P MPs significantly enhanced neovascularization and filtration of inflammatory cells |
(i) F/P MPs are good carriers of proteins in PRP and optimized the growth of human aorta endothelial cells (AECs) as well as smooth muscle cells(SMCs) | 2012 |
[45] |
(ii) Superior biological activities of GFs in PRP were demonstrated by the cultured AEC and SMCs treated with F/P MPs |
(iii) The increases in collateral arteries in ischemic limbs were significantly higher in the PRP-containing F/P MPs group than those in the F/P MPs alone, and PRP alone, in comparison to the control group. |
|
(7) Injectable biomaterial to prevent skin flap necrosis | (i) Injection of PRP and F/P MPs prior to elevation of skin flaps enriched their survival and prohibited necrosis in rodent models |
2011 |
[8] |
(ii) Histological analysis revealed that the skin flaps preinjected with PRP&F/P MPs exhibited thick granulation of tissues and neovascularization in comparison to the untreated groups |
(iii) PRP and F/P MPs are a promising injectable biomaterial in reconstructive surgery to prevent skin flap necrosis |
|
(8) Growth factor (HGF,VEGF) carrier and inducer of neovascularization | (i) FGF-2 was bounded to F/P MPs and facilitated its protections against degradation, controlled release during the culture period | 2009 |
[41] |
(ii) A week after injection, F/P MPs stimulated significant neovascularization and fibrous tissue formation |
(iii) F/P MPs biodegradation was observed 2 weeks after injection |
(i) No significant difference in blood pressure among the rabbit animal models of ischemia as revealed by laser Doppler perfusion imaging | 2011 |
[4] |
(ii) A remarkable improvement of blood pressure was observable in animals treated with F/P MPs/FGF-2 compared to the untreated ones |
(iii) Cotreatment of F/P MPs and FGF 2 significantly induced collateral blood vessel formation in rabbit ischemic models |
(iv) F/P MPS/FGF 2-induced arteriogenesis and angiogenesis in ischemic limbs present a promising for peripheral artery disease (PAD) |
(i) HGF-containing F/P MPs substantially enhanced mitogenic effect of HGF on cultured human microvascular endothelial cells | 2013 |
[5] |
(ii) The conjugation of HGF to F/P MPs facilitated the controlled release of HGF and protected these growth factors from heat and proteolytic inactivation |
(iii) F/P MPs are efficient HGF carriers that facilitate cell proliferation and vascularization of damaged tissues in mice models |
|